Semaglutide - Euro-Pharmacies

GLP-1, a peptide hormone released from intestinal L-cells, regulates blood glucose by enhancing insulin secretion. It also lowers glucagon release, reduces appetite, and decreases inflammation. Its cardiovascular benefits include protecting against ischemia and lowering cytokine production. GLP-1 receptor agonists like exendin-4 extend these effects, showing promise in neurodegenerative diseases by reducing neuroinflammation and oxidative stress. Additionally, GLP-1’s hepatic actions reduce fat accumulation and inflammation in non-alcoholic fatty liver disease (NAFLD) .

Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.

For detailed information about Semaglutide by Euro-Pharmacies, consult with your doctor or healthcare professional.